Literature DB >> 22545725

Association between ovarian hormones and smoking behavior in women.

Crystal Edler Schiller1, Michael E Saladin, Kevin M Gray, Karen J Hartwell, Matthew J Carpenter.   

Abstract

Studies examining the association between menstrual cycle phases and smoking behavior in women have yielded mixed results. The purpose of this study was to elucidate the associations between ovarian hormones and smoking by directly measuring ovarian hormone levels and obtaining a laboratory assessment of smoking behaviors. Four hypotheses were tested: Increased smoking will be associated with (1) low absolute levels of estradiol and progesterone; (2) decreasing (i.e., dynamic changes in) estradiol and progesterone; (3) lower ratios of progesterone to estradiol; and (4) higher ratios of estradiol to progesterone. Female smokers (≥10 cigarettes/day) with regular menstrual cycles were recruited as part of a larger, ongoing study examining the influence of ovarian hormones on smoking cessation treatment. Participants completed 2 study visits, including a 1-hr ad lib smoking topography session, which provided a detailed assessment of smoking behavior. Both the change in hormone levels over time and the relative ratios of ovarian hormones were associated with smoking behavior, but each to a limited extent. Decreases in estradiol (r = -.21, p = .048) and decreases in progesterone (r = -.23, p = .03) were associated with increased puff intensity. Lower ratios of progesterone to estradiol were associated with a greater number of puffs (r = -.26, p = .01) and weight of cigarettes smoked (r = -.29, p = .005). The best predictors of smoking behavior were the ratio of progesterone to estradiol (z = -2.7, p = .004) and the change in estradiol and progesterone over time (z = -2.1, p = .02). This pattern of results may help to explain inconsistent findings in previous studies and suggest potential mechanisms by which hormones influence nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22545725      PMCID: PMC3660106          DOI: 10.1037/a0027759

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  30 in total

1.  The role of carbon monoxide in cigarette smoking. I. Carbon monoxide yield from cigarettes.

Authors:  J C Robinson; W F Forbes
Journal:  Arch Environ Health       Date:  1975-09

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers.

Authors:  Mehmet Sofuoglu; Maria Mouratidis; Marc Mooney
Journal:  Psychoneuroendocrinology       Date:  2010-08-02       Impact factor: 4.905

4.  Symptomatology across the menstrual cycle in smoking and nonsmoking women.

Authors:  M DeBon; R C Klesges; L M Klesges
Journal:  Addict Behav       Date:  1995 May-Jun       Impact factor: 3.913

5.  Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder.

Authors:  J L Marks; C S Hair; S C Klock; B E Ginsburg; C S Pomerleau
Journal:  J Subst Abuse       Date:  1994

6.  Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-10       Impact factor: 17.586

7.  Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers.

Authors:  C S Pomerleau; P A Cole; M A Lumley; J L Marks; O F Pomerleau
Journal:  J Subst Abuse       Date:  1994

8.  Symptomatology and energy intake during the menstrual cycle in smoking women.

Authors:  S S Allen; D Hatsukami; D Christianson; D Nelson
Journal:  J Subst Abuse       Date:  1996

9.  Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats.

Authors:  Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2009-07-18       Impact factor: 3.533

10.  Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.

Authors:  Mehmet Sofuoglu; Ellen Mitchell; Marc Mooney
Journal:  Hum Psychopharmacol       Date:  2009-10       Impact factor: 1.672

View more
  36 in total

1.  Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Authors:  Tory A Eisenlohr-Moul; C Nathan DeWall; Susan S Girdler; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2015-03-30       Impact factor: 3.251

2.  Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers.

Authors:  Michael E Saladin; Jennifer M Wray; Matthew J Carpenter; Erin A McClure; Steven D LaRowe; Himanshu P Upadhyaya; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2014-10-16       Impact factor: 4.244

3.  Influence of menstrual cycle phase on neural and craving responses to appetitive smoking cues in naturally cycling females.

Authors:  Teresa R Franklin; Kanchana Jagannathan; Reagan R Wetherill; Barbara Johnson; Shannon Kelly; Jamison Langguth; Joel Mumma; Anna Rose Childress
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

4.  Response to nicotine following overnight smoking abstinence during short-term progesterone treatment in women.

Authors:  Sharon Allen; Ashley Petersen; Katherine Harrison; Nicole Tosun; Jacquelyn Cameron
Journal:  Exp Clin Psychopharmacol       Date:  2019-08-29       Impact factor: 3.157

5.  Smoking topography and abstinence in adult female smokers.

Authors:  Erin A McClure; Michael E Saladin; Nathaniel L Baker; Matthew J Carpenter; Kevin M Gray
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

6.  Smoking Across the Menopausal Transition in a 10-Year Longitudinal Sample: The Role of Sex Hormones and Depressive Symptoms.

Authors:  MacKenzie R Peltier; José M Flores; Philip H Smith; Walter Roberts; Terril L Verplaetse; Kelly E Moore; Robyn Hacker; Lindsay M Oberleitner; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2020-05-26       Impact factor: 4.244

7.  Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.

Authors:  Michael E Saladin; Erin A McClure; Nathaniel L Baker; Matthew J Carpenter; Viswanathan Ramakrishnan; Karen J Hartwell; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 8.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 9.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

10.  Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory.

Authors:  Raina D Pang; Madalyn M Liautaud; Matthew G Kirkpatrick; Jimi Huh; John Monterosso; Adam M Leventhal
Journal:  Neuropsychopharmacology       Date:  2017-09-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.